Encouragingly, U.S. Food and Drug Administration (FDA) has approved CD19-CAR T cell so-called Kymriah (CTL019) due to the efficient therapeutic findings, and safety for adults and children with acute lymphoblastic leukemia (ALL) [14]. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.